Wahid Boukouaci1, Laura Lauden1, Johan Siewiera2, Noemie Dam3, Hocine-Rachid Hocine1, Zena Khaznadar1, Ryad Tamouza1, Luis R Borlado4, Dominique Charron1, Nabila Jabrane-Ferrat2, Reem Al-Daccak5. 1. Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS940, Institut Universitaire d'Hématologie, Université Paris-Diderot and Laboratoire d'Immunologie et d'Histocompatibilité, Transplantex, Hôpital Saint Louis, CIB-HOG, AP-HP, Batiment Bazin, 1 Avenue Claude Vellefaux, Paris 75010, France. 2. INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. 3. Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS940, Institut Universitaire d'Hématologie, Université Paris-Diderot and Laboratoire d'Immunologie et d'Histocompatibilité, Transplantex, Hôpital Saint Louis, CIB-HOG, AP-HP, Batiment Bazin, 1 Avenue Claude Vellefaux, Paris 75010, France Coretherapix S.L., Madrid, Spain. 4. Coretherapix S.L., Madrid, Spain. 5. Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS940, Institut Universitaire d'Hématologie, Université Paris-Diderot and Laboratoire d'Immunologie et d'Histocompatibilité, Transplantex, Hôpital Saint Louis, CIB-HOG, AP-HP, Batiment Bazin, 1 Avenue Claude Vellefaux, Paris 75010, France reem.al-daccak@inserm.fr.
Abstract
AIMS: Allogeneic human cardiac-derived stem/progenitor cells (hCPC) are promising candidates for cardiac repair. They interact with T cells, major effectors of the adaptive immune response, inducing 'paracrine' anti-inflammatory effects that could sustain tissue repair/regeneration. Natural killer (NK) cells are major effectors of the innate immune system that might influence the persistence of therapeutic stem/progenitor cells. Therefore, to get through successful clinical translation and anticipate allogeneic hCPC persistence, we defined their crosstalk with NK cells under steady state and inflammatory conditions. METHODS AND RESULTS: By using an experimental model of allogeneic hCPC/NK cell interaction, we demonstrate that hCPC moderately trigger cytokine-activated, but not resting, NK cell killing that occurs through formation of lytic immunological synapse and NK cell natural cytotoxicity. Yet, inflammatory context substantially decreases their capacity to set cytokine-activated NK cell functions towards NK cell-cytotoxicity and protects hCPC from NK cell killing. Allogeneic hCPC also restrain NK cell-cytotoxicity against conventional targets and inflammatory cytokine secretion biasing the latter towards anti-inflammatory cytokines. Thus, hCPC are unprivileged targets for allogeneic NK cells and can restrain NK cell functions in allogeneic setting. CONCLUSION: Collectively, our data suggest that allogeneic hCPC/innate NK cells crosstalk within injured inflamed myocardium would permit their retention and might contribute to attenuating inflammation and to preventing adverse cardiac remodelling. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Allogeneic human cardiac-derived stem/progenitor cells (hCPC) are promising candidates for cardiac repair. They interact with T cells, major effectors of the adaptive immune response, inducing 'paracrine' anti-inflammatory effects that could sustain tissue repair/regeneration. Natural killer (NK) cells are major effectors of the innate immune system that might influence the persistence of therapeutic stem/progenitor cells. Therefore, to get through successful clinical translation and anticipate allogeneic hCPC persistence, we defined their crosstalk with NK cells under steady state and inflammatory conditions. METHODS AND RESULTS: By using an experimental model of allogeneic hCPC/NK cell interaction, we demonstrate that hCPC moderately trigger cytokine-activated, but not resting, NK cell killing that occurs through formation of lytic immunological synapse and NK cell natural cytotoxicity. Yet, inflammatory context substantially decreases their capacity to set cytokine-activated NK cell functions towards NK cell-cytotoxicity and protects hCPC from NK cell killing. Allogeneic hCPC also restrain NK cell-cytotoxicity against conventional targets and inflammatory cytokine secretion biasing the latter towards anti-inflammatory cytokines. Thus, hCPC are unprivileged targets for allogeneic NK cells and can restrain NK cell functions in allogeneic setting. CONCLUSION: Collectively, our data suggest that allogeneic hCPC/innate NK cells crosstalk within injured inflamed myocardium would permit their retention and might contribute to attenuating inflammation and to preventing adverse cardiac remodelling. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: José Luis Torán; Susana Aguilar; Juan Antonio López; Carlos Torroja; Juan Antonio Quintana; Cesar Santiago; José Luis Abad; Patricia Gomes-Alves; Andrés Gonzalez; Juan Antonio Bernal; Luis Jesús Jiménez-Borreguero; Paula Marques Alves; Luis R-Borlado; Jesús Vázquez; Antonio Bernad Journal: Sci Rep Date: 2017-10-02 Impact factor: 4.379
Authors: Arianna Mauretti; Sergio Spaans; Noortje A M Bax; Cecilia Sahlgren; Carlijn V C Bouten Journal: Stem Cells Int Date: 2017-09-17 Impact factor: 5.443